15110 North Dallas Parkway
Suite 600
Dallas, TX 75248
United States
(214) 242-9619
https://www.mangoceuticals.com
Sector(es): Healthcare
Industria: Health Information Services
Empleados a tiempo completo: 3
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Jacob D. Cohen | Co-Founder, CEO & Chairman | 278k | N/D | 1979 |
Mr. Eugene M. Johnston | Chief Financial Officer | 14k | N/D | 1964 |
Ms. Amanda Elizabeth Hammer | Chief Operating Officer | 105.42k | N/D | 1986 |
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
La calificación ISS Governance QuickScore de Mangoceuticals, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.